News and Congratulations
Congratulations to our graduates who will be presented with the Cornell University Seal, following rigorous training and multi-domain mentorship in study design, biostatistics, bioinformatics, epidemiology, molecular biology/genetics, and grantsmanship through our Clinical and Translational Education Program (CTEP). CTEP’s goal is to prepare promising physician-scientists to become the next generation of leaders in clinical and translational research.
We are thrilled to have seven trainees who have earned the Cornell seal. Each of these talented investigators share a unique vision for the future of translational medicine with the CTSC:
Thomas Baker, MD, was awarded his Master’s degree in Clinical and Translational Investigation last August and is now associate director at Janssen. His research at the CTSC focused on antimicrobial resistant infections.
Jacqueline Barrientos, MD, is an Associate Professor of hematology and medical oncology at Hofstra Northwell School of Medicine who completed a fellowship at New York Presbyterian-Weill Cornell Medical Center while pursuing her Master’s Degree in Clinical and Translational Investigation. Her Master’s thesis focused on Outcomes of Patients with Chronic Lymphocytic Leukemia After Discontinuing Idelalisib.
Jamie Bernstein, MD, is a graduate in the Weill Cornell Medical College class of 2018 who is simultaneously receiving her Master’s degree in Clinical and Translational Investigation. Jaime was awarded a TL1 training award and used this funding to research Tissue Engineering of Human Auricular Scaffolds for Clinical Application in the lab of Dr. Jason Spector. Jaime will remain at New York Presbyterian-Weill Cornell Medical Center for her residency in plastic surgery.
Ajay Gupta, MD, is an Assistant Professor of Radiology, at Weill Cornell Medicine, and a CTSC KL2 Scholar whose research centered on Nonstenosing Atherosclerotic Plaque as Cause of Cryptogenic Stroke.
Flonza Isa, MD, is an Instructor in Medicine in the division of infectious diseases at Weill Cornell Medicine, and a CTSC KL2 Scholar studying Urinary biomarkers for Mycobacterium tuberculosis.
Shashi Kapadia, MD, is an Instructor of Medicine in the division of infectious diseases at Weill Cornell Medicine. Shashi was awarded his Master’s Degree in Clinical and Translational Investigation in August 2017. His research thesis was on barriers to hepatits C treatment in the United States from a public health perspective.
Matthew Wipperman, PhD, is a postdoctoral research fellow at Memorial Sloan Kettering Cancer Center and a TL1 Training Awardee at the CTSC. His research is on Microbiomic correlates of Tuberculosis infection and antimycobacterial treatment.